Fiserv Inc. (NYSE:FI) is one of the best IT stocks to invest in according to hedge funds. On September 8, Fiserv announced ...

Fiserv, Inc. (NYSE:FI) is one of the Best Low Cost Stocks to Buy According to Analysts. On September 4, Fiserv, Inc. (NYSE:FI) announced the acquisition of CardFree, a platform offering order, payment ...

United States-based payment giants and fast-growing fintechs are grabbing a larger slice of market share for local terminals and transaction processing, denting the dominance of the big four banks and ...

Levi & Korsinsky, LLP notifies investors in Fiserv, Inc. (NYSE: FI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fiserv, Inc. investors who ...

Fiserv, Inc. (NYSE: FI) is one of the Top Large Cap Stocks to Buy At 52-Week Low. On September 5, Fiserv, Inc. (NYSE:FI) ...

A class action securities lawsuit was filed against Fiserv, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between July 24, 2024 and July 22, ...

With a one-year share price decline and significant hedge fund interest, Fiserv, Inc. (NYSE:FI) secures a spot on our list of the 12 Best Stocks to Buy in Falling Markets According to Hedge Funds.

We expect Clover to continue gaining market share and Fiserv to compound EPS at a double-digit rate over many years." A businessman at a smart POS terminal ... check out our report about this cheapest ...

While students shuffled off of campus and spent the summer with family and friends, Chico State continued to move along. Here ...

Payments technology company Fiserv has announced two strategic acquisitions aimed at expanding the capabilities of its Clover ...

Fiserv, Inc., a leading global provider of payments and financial services technology, today announced it has acquired CardFree, an all-in-one platform empowering merchants with customized order, pay, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Clover Biopharmaceuticals Ltd. ( (HK:2197 ...